Neurology Medical Journal Article Reports Two-Times Increased Risk For This Nerve Damage Side Effect For New Users Of These Antibiotics
SUMMARY: The first large epidemiologic study has confirmed this link between Avelox, Cipro, and Levaquin with peripheral neuropathy. On August 22, 2014 the article, “Oral fluoroquinolone use and risk of peripheral neuropathy”, reporting about that study was published online before print by the medical journal Neurology.
The study was led by Dr. Mahyar Etminan, a drug safety researcher at the University of British Columbia. This study, which involved one million men, showed the current users of Cipro, Levaquin, and Avelox are approximately two-times more like to develop peripheral neuropathy than non-users. Significantly, this increased risk of developing peripheral neuropathy was similar across all the three of these brand name fluoroquinolone antibiotics.
We will continue to monitor this relatively unknown, still emerging drug safety issue and and report significant developments here.[Read this article in full at original source]
Strictly Confidential, No Obligation